BWL
BIIB icon

Bogart Wealth LLC’s Biogen BIIB Stock Holding History

Bogart Wealth LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.5K Buy
220
+5
+2% +$956 ﹤0.01% 550
2026
Q1 		$39.4K Sell
215
-294
-58% -$54.2K ﹤0.01% 554
2025
Q4 		$89.6K Buy
509
+196
+63% +$32K ﹤0.01% 354
2025
Q3 		$43.8K Buy
313
+104
+50% +$14.1K ﹤0.01% 490
2025
Q2 		$26.2K Hold
209
– – ﹤0.01% 575
2025
Q1 		$28.6K Hold
209
– – ﹤0.01% 511
2024
Q4 		$32K Hold
209
– – ﹤0.01% 491
2024
Q3 		$40.5K Hold
209
– – ﹤0.01% 450
2024
Q2 		$48.5K Sell
209
-8
-4% -$1.74K ﹤0.01% 414
2024
Q1 		$46.8K Sell
217
-11
-5% -$2.58K ﹤0.01% 394
2023
Q4 		$59K Hold
228
– – ﹤0.01% 349
2023
Q3 		$58.6K Buy
228
+8
+4% +$2.14K ﹤0.01% 325
2023
Q2 		$62.7K Buy
220
+20
+10% +$5.95K ﹤0.01% 303
2023
Q1 		$55.6K Hold
200
– – ﹤0.01% 304
2022
Q4 		$55.4K Hold
200
– – ﹤0.01% 293
2022
Q3 		$53K Hold
200
– – ﹤0.01% 288
2022
Q2 		$41K Buy
200
+184
+1,150% +$37.6K ﹤0.01% 310
2022
Q1 		$3K Sell
16
-7
-30% -$1.52K ﹤0.01% 624
2021
Q4 		$6K Buy
23
+18
+360% +$4.63K ﹤0.01% 527
2021
Q3 		$1K Sell
5
-10
-67% -$3.28K ﹤0.01% 665
2021
Q2 		$5K Sell
15
-1
-6% -$303 ﹤0.01% 509
2021
Q1 		$4K Buy
16
+4
+33% +$1.08K ﹤0.01% 495
2020
Q4 		$2K Sell
12
-2,270
-99% -$586K ﹤0.01% 397
2020
Q3 		$647K Buy
2,282
+440
+24% +$123K 0.14% 93
2020
Q2 		$493K Buy
1,842
+330
+22% +$99.2K 0.12% 98
2020
Q1 		$478K Buy
1,512
+289
+24% +$87.7K 0.13% 84
2019
Q4 		$363K Buy
1,223
+66
+6% +$18.3K 0.12% 89
2019
Q3 		$269K Buy
1,157
+88
+8% +$20.5K 0.13% 84
2019
Q2 		$250K Buy
1,069
+266
+33% +$61.4K 0.15% 82
2019
Q1 		$189K Buy
+803
New +$253K 0.09% 88

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bogart Wealth LLC's BIIB Position: Q2 2026 in Review

Bogart Wealth LLC increased its Biogen (BIIB) stake by 2.3% in Q2 2026, buying an estimated $956 and bringing the position to 220 shares worth $47.5K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Bogart Wealth LLC first reported a position in BIIB in Q1 2019 and has held it in 30 quarters since. The position peaked at $647K in Q3 2020. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Bogart Wealth LLC held 220 shares of Biogen worth $47.5K as of Q2 2026.
  • Bogart Wealth LLC bought 5 Biogen shares in Q2 2026, an estimated $956.
  • Biogen made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #550 holding.
  • Bogart Wealth LLC first reported a position in Biogen in Q1 2019 and has held it in 30 quarters since.
  • Bogart Wealth LLC's Biogen position peaked at $647K in Q3 2020.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.